« zurück zur Übersicht
Chandra, Pranjal:
Diagnostic Strategies for COVID-19 and other Coronaviruses
Bezug PRÜFEN, da Springer Singapure!
Preis: 160,49 Euro
Verlag: Springer
Erscheinungsdatum: 01/2021
Seiten: 290 pp.
Abbildungen: 15 s/w + 48 Farbabb.
ISBN-10: 981-15-6005-6
ISBN-13: 978-981-15-6005-7
» In den Warenkorb
Diagnostic Strategies for COVID-19 and other Coronaviruses
Bezug PRÜFEN, da Springer Singapure!
Preis: 160,49 Euro
Verlag: Springer
Erscheinungsdatum: 01/2021
Seiten: 290 pp.
Abbildungen: 15 s/w + 48 Farbabb.
ISBN-10: 981-15-6005-6
ISBN-13: 978-981-15-6005-7
» In den Warenkorb
Beschreibung
Examines various strategies for the detection of SARS-CoV-2
Presents CRISPR-Cas 12- (Integrative) based techniques for the detection of SARS-CoV-2
Discusses RT-PCR, RT-LAMP, and immunodiagnostic tests for the detection of SARS-CoV-2
Summarizes the use of miniature biosensors for the detection of other types of coronavirus
Presents CRISPR-Cas 12- (Integrative) based techniques for the detection of SARS-CoV-2
Discusses RT-PCR, RT-LAMP, and immunodiagnostic tests for the detection of SARS-CoV-2
Summarizes the use of miniature biosensors for the detection of other types of coronavirus
Vorteile
This book provides fundamental information on various techniques for the detection of SARS-CoV-2 including reverse transcriptase (RT) PCR, loop-mediated isothermal amplification, immunodiagnostic tests, and CRISPR-Cas. It reviews various testing kits and detection methodologies that are currently being used for the detection of SARS-CoV-2 and examines strategies for the post-treatment detection and monitoring of SARS-CoV-2. Further, it assesses the diagnostic potential of several SARS-CoV-2 proteins; and analyzes their structural determinants and immunogenicity.
In turn, the book evaluates the potential of CRISPR-Cas 12-based assays for the detection of SARS-CoV-2 using RNA extracted from patients. Lastly, it discusses the use of miniaturized biosensors for the detection of other types of coronavirus.
In turn, the book evaluates the potential of CRISPR-Cas 12-based assays for the detection of SARS-CoV-2 using RNA extracted from patients. Lastly, it discusses the use of miniaturized biosensors for the detection of other types of coronavirus.